迈得医疗
(688310)
| 流通市值：28.26亿 | | | 总市值：28.26亿 |
| 流通股本：1.64亿 | | | 总股本：1.64亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 39,857,551.99 | 447,418,984.29 | 224,643,650.85 | 141,000,652.85 |
| 营业收入 | 39,857,551.99 | 447,418,984.29 | 224,643,650.85 | 141,000,652.85 |
| 二、营业总成本 | 70,531,168.22 | 414,721,751.3 | 246,657,062.76 | 156,540,560.82 |
| 营业成本 | 28,042,668.49 | 247,575,402.37 | 134,362,178.2 | 86,111,225.43 |
| 税金及附加 | 1,749,244.3 | 6,827,293.84 | 5,130,573.09 | 3,623,805.82 |
| 销售费用 | 9,489,453.45 | 35,494,255.47 | 19,892,181.84 | 11,892,223.99 |
| 管理费用 | 18,096,370.39 | 77,798,269.05 | 56,682,363.02 | 37,755,216.77 |
| 研发费用 | 11,731,370.73 | 47,200,257.98 | 31,113,408.83 | 17,977,238.05 |
| 财务费用 | 1,422,060.86 | -173,727.41 | -523,642.22 | -819,149.24 |
| 其中:利息费用 | 489,939.69 | 1,596,861.45 | 1,119,302.28 | 652,400.18 |
| 其中:利息收入 | 432,330.61 | 1,921,413.76 | 1,118,713.5 | 718,745.49 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,117,877.68 | 3,804,858 | 2,358,333.06 | 1,270,153.83 |
| 加:投资收益 | 18,807.73 | 607,155.46 | 167,605.31 | 174,638.08 |
| 资产处置收益 | 12,663.17 | -51,293.81 | -59,989.15 | -39,911.63 |
| 资产减值损失(新) | -846,629.87 | -2,038,568.27 | -1,242,209.7 | -667,413.23 |
| 信用减值损失(新) | 2,685,486.4 | 1,037,774.58 | 566,691.31 | 938,013.27 |
| 其他收益 | 3,704,610.52 | 23,362,065.95 | 19,223,165.5 | 14,959,311.46 |
| 四、营业利润 | -23,980,800.6 | 59,419,224.9 | -999,815.58 | 1,094,883.81 |
| 加:营业外收入 | 6,481.68 | 2,383,213.47 | 2,382,865.17 | 2,382,861.2 |
| 减:营业外支出 | 29,096.8 | 858,967.06 | 631,838.29 | 298,911.17 |
| 五、利润总额 | -24,003,415.72 | 60,943,471.31 | 751,211.3 | 3,178,833.84 |
| 减:所得税费用 | 502,662.3 | 16,374,323.15 | 6,213,297.59 | 4,998,260.08 |
| 六、净利润 | -24,506,078.02 | 44,569,148.16 | -5,462,086.29 | -1,819,426.24 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -24,506,078.02 | 44,569,148.16 | -5,462,086.29 | -1,819,426.24 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -19,034,802.5 | 64,941,657.57 | 8,836,659.11 | 6,045,058.94 |
| 少数股东损益 | -5,471,275.52 | -20,372,509.41 | -14,298,745.4 | -7,864,485.17 |
| 扣除非经常损益后的净利润 | -20,740,811.68 | 52,913,651.68 | -1,278,531.67 | -2,514,883.74 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.12 | 0.4 | 0.05 | 0.04 |
| (二)稀释每股收益 | -0.12 | 0.4 | 0.05 | 0.04 |
| 八、其他综合收益 | 302,638.17 | -699,886.91 | -798,404.99 | -864,783.7 |
| 归属于母公司股东的其他综合收益 | 302,638.17 | -699,886.91 | -798,404.99 | -864,783.7 |
| 九、综合收益总额 | -24,203,439.85 | 43,869,261.25 | -6,260,491.28 | -2,684,209.94 |
| 归属于母公司股东的综合收益总额 | -18,732,164.33 | 64,241,770.66 | 8,038,254.12 | 5,180,275.24 |
| 归属于少数股东的综合收益总额 | -5,471,275.52 | -20,372,509.41 | -14,298,745.4 | -7,864,485.17 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-28 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |